Neulasta ® Onpro ® reduces the risk of febrile neutropenia without having to go back to the doctor's office*

Some patients find it hard to return to their physician the next day to receive Neulasta ® , and missing a dose of Neulasta ® can increase the risk of febrile neutropenia. With Onpro ® , patients can receive Neulasta ® at home so they don't have to go back to the doctor on the day after chemo.

\n ">,<"name":"ReusableRichText","path":"main--0","contents":" \n

Neulasta ® Onpro ® may be able to help
\nwith these common challenges

For many patients, there’s no place like home the day after chemo. There’s no reason to make trips back to the doctor if you can stay at home instead. Ask your doctor if Neulasta ® Onpro ® is right for you.

Neulasta ® Onpro ® may be right for you if you are an adult, are comfortable with the patient instructions for use, and have no allergies to acrylics.

Exposure to viruses
\nPeople with a weakened immune
\nsystem may want to stay away
\nfrom those with a viral infection.

Struggle to get transportation
\nFor some, getting a ride can be difficult.

Live far away
\nDriving is part of the
\ntime you
\nspend going
\nto an appointment.

One less trip back to
\nthe doctor’s office
\n Neulasta ® Onpro ® was
\ndesigned so you can stay home* to get your dose.

Bad weather
\nAvoid the elements and
\ndangerous conditions.

Chemo before
\nholidays & weekends
\nChemo on a day before
\nnext-day office closings.

* If, for any reason, you believe you did not receive your full dose of Neulasta ® or that your on-body injector is not working correctly, immediately contact your healthcare provider, as an incomplete dose could increase infection risk.

Neulasta ® Onpro ® is designed to automatically deliver Neulasta ® the next day—so you don't have to leave your home to go back to the doctor's office.

What patients think

95% of patients would choose Onpro ® again

Before your first round of chemo, ask your doctor if Neulasta ® Onpro ® can be part of your treatment plan.

How the Neulasta ® Onpro ®
\non-body injector works

Right after your strong chemo treatment, your healthcare provider will apply the on-body injector to your skin. The on-body injector is designed to automatically deliver your Neulasta ® dose over 45 minutes, approximately 27 hours after application. Once your dose is complete, remove the injector and dispose of it according to the Patient Instructions for Use.

The summary does not replace the Patient Instructions for Use. If you are using Neulasta ® Onpro ® , it’s
\nimportant that you review the patient instructions and call your doctor if you have any questions.

\n Fill indicator
\n The black line should be at “FULL” until dose
\n delivery starts. Check your instructions for
\n use for more information. \n

\n Adhesive pad
\n The pad attaches the on-body injector directly on
\n the skin on the back of your arm or abdomen. \n

\n Cannula window
\n Allows you to view the cannula
\n (a short, soft tube) that your
\n Neulasta ® passes through during
\n the 45-minute dose delivery. \n

\n Audio
\n When you hear a beep, check the status light
\n and fill indicator. See your instructions for use
to understand what these signals mean. \n

\n Status light \n Flashing green: On-body injector is working properly. \n Solid green (or turned off): Medication delivery should be complete. Check to see if the fill indicator reads “empty” and there is no noticeably wet adhesive. \n Flashing red: On-body injector error—call your healthcare provider immediately. \n

Applying and removing the on-body injector

Watch this overview video to learn more about how your healthcare provider will apply the Neulasta ® Onpro ® on-body injector, how it is removed, and what to expect the next day.

This video does not replace the instructions for use. Please consult the instructions for
\nuse when using the Neulasta ® Onpro ® kit.

A PodPal™ adds extra adhesion

\n For a more secure fit, an adhesive extender that fits around the on-body injector called a PodPal™ may be added by your doctor or nurse if they deem it appropriate. You can also ask your doctor or nurse about adding a PodPal™ when they put your Onpro ® on-body injector in place. \n

\n The product information provided in this site is intended only for residents of the United States. \n The products discussed herein may have different product labeling in different countries. \n Neulasta ® is a registered trademark and Onpro ® is a trademark of Amgen Inc. \n

\n Important Safety Information

\n Do not take Neulasta ® if you have had a serious allergic reaction to pegfilgrastim or filgrastim. \n

Before you receive Neulasta ® , tell your healthcare provider about all of your healthcare conditions, including if you:

\n
• Have a sickle cell disorder \n
• Have had severe skin reactions to acrylic adhesives \n
• Are allergic to latex – The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). \n
• Have kidney problems \n
• Are pregnant or plan to become pregnant. It is not known if Neulasta ® may harm your unborn baby. \n
• Are breastfeeding or plan to breastfeed. It is not known if Neulasta ® passes into your breast milk. \n

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible serious side effects of Neulasta ® ?

\n
• Spleen Rupture. Your spleen may become enlarged and can rupture while taking Neulasta ® . A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder tip area. \n
• A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing. \n
• Serious Allergic Reactions. Neulasta ® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate and sweating. \n

If you have an allergic reaction during the delivery of Neulasta ® , remove the on-body injector for Neulasta ® by grabbing the edge of the adhesive pad and peeling off the on-body injector. Get emergency medical help\n right away.

\n
• Sickle Cell Crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive Neulasta ® . \n
• Kidney injury (glomerulonephritis). Neulasta ® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face or ankles, blood in your urine or dark colored urine, or you urinate less than usual. \n
• Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with Neulasta ® . \n
• Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with Neulasta ® . Tell your healthcare provider if you have unusual bleeding or bruising during treatment with Neulasta ® . This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot. \n
• Capillary Leak Syndrome. Neulasta ® can cause fluid to leak from blood vessels into your body’s tissues. This condition is called \"Capillary Leak Syndrome\" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: \n
  \n
  • Swelling or puffiness and are urinating less than usual \n
  • Trouble breathing \n
  • Swelling of your stomach area (abdomen) and feeling of fullness \n
  • Dizziness or feeling faint \n
  • A general feeling of tiredness \n

  The most common side effect of Neulasta ® is pain in your bones and in your arms and legs.

  These are not all the possible side effects of Neulasta ® . Call your healthcare provider for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.

  Neulasta ® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only.

  Neulasta ® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe co-packaged with the on-body injector (OBI) for Neulasta ® (Neulasta ® Onpro ® kit).